Wall Street Legend Who Bought Streaming Giant for $2 Calls This the “Investment of the Century”

Paul Mampilly is no stranger to extraordinary profits.

In 2008, he was practically laughed out of the room by his colleagues on Wall Street when he was keen on a little-known streaming company for around $2 a share after it had traded sideways for a decade.

That stock was Netflix, and today it trades for more than $300 a share.

But that wasn’t the only time Paul was keen to buy in on a stock early.

In April 2012, he invested in a company by the name of Sarepta Therapeutics when it was in the infancy stage of developing a drug to treat muscular dystrophy.

Eight months later, he sold his stake for a 2,539% gain.

And those weren’t Paul’s only big winners. He cashed out with a 279% gain on Facebook, 355% on Exact Sciences, 264% on Stratysys, 696% on Ariad Pharmaceuticals, 736% on Coeur Mining, and recently bagged a 1,264% gain on a company called Staar Surgical in just 10 days.

As remarkable as these gains are, Paul says they pale in comparison to the potential he sees in a new technology that some experts are calling “one of the most significant discoveries since fire.”

Microsoft is investing $12 billion in this technology.

IBM is investing $15 billion.

Google is going all in with $30 billion.

And Intel has already put up $32 billion.

And yet, just recently, the market for this technology was valued at just $20 billion.

However, it’s potential market is so massive that experts predict it will surge into a $15.7 trillion industry in just a handful of years.

That’s 76,000% growth!

Paul says an investment opportunity like this has never before been seen in our lifetimes, and that those who get in today will be positioned for what he calls “the investment opportunity of the century.”

That’s why Paul recently delivered a live presentation to a small group of wealthy entrepreneurs and investors, telling them to quickly buy the company at the forefront of this technology, while it trades for just 1/30th the price of its biggest competitors.

While this presentation was originally intended for a small audience. However, Paul has agreed to allow us to host the video on our website for a limited time.

There’s no telling how long we’ll be able to keep this video online. It could be pulled off in the next few days.

You can watch Paul’s live presentation here.

 

 

 


Legal Notice: This work is based on what we’ve learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It’s your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Don’t trade in these markets with money you can’t afford to lose. Investing in stock markets involves the risk of loss. Before investing you should consider carefully the risks involved, if you have any doubt as to suitability or the taxation implications, seek independent financial advice. Banyan Hill Publishing expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Banyan Hill Publishing, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail.

(c) 2018 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096)